Letter to "Preoperative Prediction of Microvascular Invasion by EOB-MRI Imaging for Surgical Decision"
- PMID: 40547963
- PMCID: PMC12180798
- DOI: 10.1159/000541884
Letter to "Preoperative Prediction of Microvascular Invasion by EOB-MRI Imaging for Surgical Decision"
Keywords: Hepatocellular carcinoma; Magnetic resonance imaging; Microvascular invasion; Recurrence and survival; Surgery.
Conflict of interest statement
Tung-Hung Su received research grant from Gilead Sciences, served as a consultant for Gilead Sciences, and was on speaker’s bureaus for Abbott, Abbvie, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp and Dohme, Roche and Sysmex.
References
-
- Kim NR, Bae H, Hwang HS, Han DH, Kim KS, Choi JS, et al. Preoperative prediction of microvascular invasion with gadoxetic acid-enhanced magnetic resonance imaging in patients with single hepatocellular carcinoma: the implication of surgical decision on the extent of liver resection. Liver Cancer. 2024;13(2):181–92. - PMC - PubMed
-
- Li J, Su X, Xu X, Zhao C, Liu A, Yang L, et al. Preoperative prediction and risk assessment of microvascular invasion in hepatocellular carcinoma. Crit Rev Oncol Hematol. 2023;190:104107. - PubMed
-
- Chen M-F, Ho MC, Kao JH, Hwang RM, Deng SB, Yen KC, et al. Comparison of CT and gadoxetic acid–enhanced MRI with liver imaging reporting and data system to assess liver tumors before resection. J Formos Med Assoc. 2024;123(3):318–24. - PubMed
-
- Wu C-H, Lee YH, Liang PC, Hu RH, Shih TTF, Ho MC. Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma. J Formos Med Assoc. 2022;121(8):1550–9. - PubMed
-
- Zhou L, Qu Y, Quan G, Zuo H, Liu M. Nomogram for predicting microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI and intravoxel incoherent motion imaging. Acad Radiol. 2024;31(2):457–66. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
